- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00149695
Soft Drink, Milk and Obesity in Chilean Children
20. august 2010 opdateret af: Boston Children's Hospital
The primary aim of this randomized controlled trial is to evaluate the effects of replacing habitual consumption of sugar-sweetened soft drinks with milk over 16 weeks.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The prevalence of obesity has risen dramatically among children in the U.S. and throughout the world since the 1960s.
Many factors are thought to have contributed to the epidemic of pediatric obesity.
One factor that has received increasing attention is consumption of sugar-sweetened beverages.
Feeding studies suggest physiological mechanisms by which sugar in liquid form may be less satiating than other foods.
An observational study found total energy consumption to be greater among children who consume sugar-sweetened beverages compared to non-consumes.
Short-term interventional studies report increasing energy intake and body weight in subjects given sugar-sweetened beverages compared to non-caloric beverages.
Our preliminary data found that the risk for becoming obese increased by about 60% in middle school children for every additional serving per day of sugar-sweetened beverage consumed.
The purpose of the present study is to conduct a 16-week clinical trial involving 96 children ages 8 to 10 years in Chile, a developing nation characterized as undergoing a "nutrition transition."
The subjects, selected for current sugar-sweetened soft drink consumption, will be randomly assigned to intervention or control groups.
The intervention group will be encouraged to substitute milk products for soft-drinks; to facilitate this dietary change, a variety of milk products will be delivered to subjects' homes on a weekly basis.
Clinical endpoints include changes in dietary quality, body weight, adiposity by DEXA-scan and measures of calcium homeostasis.
Undersøgelsestype
Interventionel
Tilmelding
96
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
-
Santiago, Chile
- INTA - University of Chile
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
8 år til 10 år (Barn)
Tager imod sunde frivillige
Ja
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Male or female, age 8 to 10 years
- Tanner Stage I
- BMI between 85th and 95th percentiles for age and gender
- Consuming at least 2 servings/day of sugar-sweetened beverages
- Willingness to consume milk instead of sugar-sweetened beverages for 16 weeks
- Able to read Spanish and accurately complete dietary assessments
Exclusion Criteria:
- Presence of a serious underlying medical condition
- Taking any medication that affects body weight
- History of lactose intolerance or milk protein allergies
- History of an eating disorder
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
|---|
|
Change in percent body fat by DXA scan
|
Sekundære resultatmål
Resultatmål |
|---|
|
Blodsukker
|
|
BMI
|
|
Blood insulin
|
|
Serum lipids
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Samarbejdspartnere
Efterforskere
- Studieleder: Cara B Ebbeling, PhD, Boston Children's Hospital
- Ledende efterforsker: Cecilia Albala, MD, INTA - University of Chile
- Studieleder: Mariana Cifuentes, PhD, INTA - University of Chile
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Generelle publikationer
- Ludwig DS, Peterson KE, Gortmaker SL. Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis. Lancet. 2001 Feb 17;357(9255):505-8. doi: 10.1016/S0140-6736(00)04041-1.
- Pereira MA, Jacobs DR Jr, Van Horn L, Slattery ML, Kartashov AI, Ludwig DS. Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study. JAMA. 2002 Apr 24;287(16):2081-9. doi: 10.1001/jama.287.16.2081.
- Albala C, Ebbeling CB, Cifuentes M, Lera L, Bustos N, Ludwig DS. Effects of replacing the habitual consumption of sugar-sweetened beverages with milk in Chilean children. Am J Clin Nutr. 2008 Sep;88(3):605-11. doi: 10.1093/ajcn/88.3.605.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. juli 2004
Studieafslutning (Faktiske)
1. december 2005
Datoer for studieregistrering
Først indsendt
31. august 2005
Først indsendt, der opfyldte QC-kriterier
6. september 2005
Først opslået (Skøn)
8. september 2005
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
24. august 2010
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
20. august 2010
Sidst verificeret
1. august 2010
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- TW006818-Fogarty (completed)
- R03TW006818 (U.S. NIH-bevilling/kontrakt)
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .